On Apirl 16th 2020, the novel coronavirus (2019) PCR test kit developed by Jiangsu Bioperfectus was officially approved by China's NMPA (National Medical Products Administration)（NMPA(III): 20203400384). This kit has been CE marked on March 6th 2020, and widely used in China as well as some foreign countries such as Thailand, Myanmar, Czech, Spain and etc.

Since the gene sequence of SARS-CoV-2 was decoded and jointly announced by National Health Commission (NHC) of the People’s Republic of China and World Health Organization, Bioperfectus team worked through night and day and developed COVID-19 real-time PCR kit within 72 hours. The maximum COVID-19 real-time PCR kit productivity is around 500 thousand testing per day.

FEATURES：

1.High sensitivity and specificity

2.Short turn around time within 1.5 hour

3. Multiplex real-time PCR

4.Reliable Clinical performance

5. Include whole-process quality control